Janne Backman
FinlandJanne T. Backman, MD, PhD is Professor in Clinical Pharmacology and Individual Medicine at Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Finland. He is the current president elect of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and the Chairman of the Organizing Committee of 17th EACPT Congress to be held in Helsinki in 2025.
In 2019, he was nominated as a member of the Finnish Academy of Science and Letters for his merits in his scientific discipline. Dr. Backman’s research interests have focused on drug–drug interactions and other sources of individual variability in pharmacokinetics. He has published about 200 original articles in international peer-reviewed journals, and his H-index is 69 (Scopus, April 1, 2024).
Gerard Rongen
The NetherlandsAs a member of the board of the Dutch Society for Clinical Pharmacology and Biopharmacy and one of the organizers of the annual FIGON-Dutch Medicines Days, he regards as his mission to improve the synergy between the various Dutch scientific societies, public and commercial partners who are involved in development of new pharmaco-therapeutic strategies and optimization of current pharmacotherapy in terms of efficacy and safety.
Joaquín Sáez Peñataro
SpainPhysician, specialized in Clinical Pharmacology (medical residency 2011 – 2015).
Joaquín Sáez-Peñataro, MD. Clinical Pharmacologist based in Hospital Clínic de Barcelona, Spain. Specialized in pharmacovigilance and vaccinovigilance. He is also part of the Advanced Therapies Committee and the Research Ethics Committee of the Hospital.
Associate professor of University of Barcelona. Secretary of EACPT. Treasurer of Spanish Association for Clinical Pharmacology and Therapeutics (SEFC).
Julia Stingl
GermanyJulia is professor and medical director of the department of clinical pharmacology and pharmacoepidemiology at the university hospital Heidelberg since 2025. From 2019 – 2024 she was head of the institute of clinical pharmacology at the university hospital of the RWTH Aachen. In the years 2012-2019, she was head of research and vice president of the German drug regulatory authority, BfArM. Her research mostly focuses on Personalized Medicine and pharmacogenetic risk profiles for adverse drug events and therapeutic failure. She pioneered the systematic development of personalized dose adjustments promoting the way of pharmacogenetic information in drug labels. She is involved in many European projects, such as the EraPerMed project Artipro, and the Horizon Europe project SafePolyMed. J Stingl has authored more than 280 publications in peer-reviewed scientific journals, has been cited more than 12,000 times with an average citation of 30 per article and an H-index of 57.
Julia was recipient of the Utrecht Award for Pharmaceutical Research in 2009 and awarded with the Leon I. Goldberg Young Investigator Award of the American Society for Clinical Pharmacology and Therapeutics in 2010.
Julia was member of the former Pharmacogenomics Working Party and now serves as expert for the European Medicines Agency (EMA). Since 2019, she is member of the gene diagnostic committee in Germany. Since 2004 she is extraordinary member of the Drug Commission of the German Medical Association (AKDAE).
Troels K. Bergmann
DenmarkClinical Professor and Consultant, MD, PhD
University of Southern Denmark, Odense University Hospital and Esbjerg Grindsted Hospital, Denmark
The overarching theme of TKB’s research is the unraveling of the variability of drug responses in humans, with a focus on pharmacogenetics, drug-drug interactions, and both basic and advanced pharmacokinetic modeling.
Pierre Marquet
FrancePierre MARQUET is a medical doctor with a PhD in physiology. Since 2001 he has been a full professor of clinical pharmacology at the Faculty of Medicine of Limoges, France. He currently serves as:
– Head of the “Pharmacology, Toxicology and Pharmacovigilance” Department at the University Hospital of Limoges since 2011
– Director of the “Pharmacology & Transplantation” research unit (UMR1248 INSERM) since 2007
– Honorary President of the European Association for Clinical Pharmacology and Therapeutics (EACPT)
– Treasurer of the International Union of Basic & Clinical Pharmacology (IUPHAR) for the 2022-2026 term
Pierre Marquet conducts translational research in personalized medicine, with a particular focus on organ transplantation. He has been the principal investigator of approximatively 20 clinical trials and cohort studies, and has authored more than 570 publications indexed in the Web of Science (>11,000 citations, H-index = 58).
Laura Aurinsalo
FinlandCo-chair of the EACPT Early-Career Clinical Pharmacologist Working Group.
Laura Aurinsalo is both a resident in clinical pharmacology at the Helsinki University Hospital and a doctoral researcher at the University of Helsinki. Her research focuses on drug-drug interactions and drug metabolism phenotyping. She serves as Co-Chair of the EACPT Early Career Clinical Pharmacologists Working Group and is also a member of the Communication Working Group. She was the responsible lead for the early-career premeeting at the EACPT2025 congress which was held in Helsinki, the capital city of Finland.
Andrej Belančić
CroatiaCo-chair of the EACPT Early-Career Clinical Pharmacologist Working Group.
Andrej Belančić is a specialist in clinical pharmacology and toxicology at the Clinical Hospital Centre Rijeka and the University of Rijeka Faculty of Medicine, serving also as Co-Chair of the EACPT Early Career Clinical Pharmacologists Working Group and EASO ECN Board Representative for the Middle Europe Region. He strongly advocates mentorship, collaboration, networking, and building a sustainable cycle of scientific excellence.
Jelle Tichelaar
The Netherlands – Chair of the Education WGDr. Jelle Tichelaar is a clinical pharmacologist and Associate Professor at the Department of Internal Medicine, Amsterdam UMC. He obtained his PhD in 2016 on context-based pharmacotherapy education and received the NVKFB Best Thesis Award in Clinical Pharmacology.
His work focuses on pharmacotherapy education, prescribing competence, interprofessional collaboration, and medication safety at local, national, and European levels (see https://pure.amsterdamumc.nl/en/persons/jelle-tichelaar/).
He currently chairs the Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and the Education Committee of the Dutch Society for Clinical Pharmacology and Biopharmacy (NVKFB).
Concepción Payares
SpainCo-Chair of the Regulatory Working Group
Concepción Payares is a physician, specialized in Clinical Pharmacology, and holds a PhD in Medicine by Universidad de Cádiz, Spain. She is currently working as a Clinical Pharmacologist at the Department of Clinical Pharmacology in Hospital Puerta de Hierro (Madrid, Spain), with special focus on Precision Medicine and Treatment individualization, as well as Patient Safety.
Concepción is a clinical expert for the Spanish Medicine Agency (AEMPS) and the European Medicines Agency (EMA), since 2011- present, with regulatory and methodological expertise in ATMP, Oncology, Autoimmune diseases, Diabetes.
Elected member of the Executive Board of the Spanish Society of Clinical Pharmacology (2022-present) and co-opted member of the Executive Committee of EACPT (2023-present).
Lucía Arellano
SpainCo-Chair of the Regulatory Working Group
Clinical Pharmacologist working at the intersection of clinical research, research ethics, regulatory science, and artificial intelligence in health.
Experienced in supporting and advising Research Ethics Committees on the evaluation and governance of biomedical research, including clinical trials and studies involving health data. Contributes to ethical and regulatory oversight at both national and European levels, including participation in the MedEthicsEU programme.
Research interests focus on AI governance in biomedical research, ethical and regulatory frameworks for data-driven tools, transparency and bias mitigation in algorithms, and the responsible integration of artificial intelligence into clinical research and healthcare systems.
Assistant Professor in Clinical Pharmacology with experience in undergraduate and postgraduate medical education.
PhD (Cum Laude) from the Universitat Autònoma de Barcelona, with research focused on pharmacovigilance and drug safety.
Lucía Bellas
SpainChair of the Communication Working Group
Medical Doctor specialized in Clinical Pharmacology, with expertise in pharmacoepidemiology and Real-World Evidence, the focus of her PhD research.
Currently working as an epidemiologist within the EHDEN Foundation (European Health Data & Evidence Network), contributing to federated data research and real-world evidence generation in European projects.
Experience includes pharmacovigilance, clinical trial development, ethics in medicinal products and medical devices, as well as drug selection and regulatory affairs.
Florian Naudet
FranceFlorian is a psychiatrist and meta-researcher. He’s currently teaching Therapeutics at Rennes 1 University, France. His research interests are evaluating and developing methodological solutions to assess treatments in patients, primarily but not exclusive in psychiatric research.
Ivana Kacirova
Czech RepublicIvana Kacirová, MD, PhD. is a clinical pharmacologist. She works as the Head of the Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Czech Republic. She specializes in therapeutic drug monitoring. She is also the Chairman of the Ethics Committee and a member of the Hospital’s Drug Committee. She is the Head of the Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Czech Republic and the Chair of the Czech Society of Clinical Pharmacology and the Section of Therapeutic Drug Monitoring of the Czech Society of Clinical Pharmacology.
Arne Reimers
Clinical pharmacologist with profound professional experience from academia, industry, hospital, and research. Main interests include neuropharmacology, drug-induced cognitive impairment, and epigenetic pharmacology incl. RNA-based diagnostics and treatment. PhD (dr. med.) in 1991 (Germany), second PhD (dr. philos.) in 2011 (Norway), associate professor 2014 (Norway). Former chair of the Norwegian Association of Clinical Pharmacology. Currently the head of Clinical Pharmacology, Lund University Hospital, Lund, Sweden and vice-chair of the Swedish Association of Basic and Clinical Pharmacology.
Jan de Hoon
Belgium – Center for Clinical Pharmacology / University Hospitals Leuven, BelgiumAfter obtaining a Master’s degree in chemistry and becoming a Medical Doctor, Jan specialised in General Internal Medicine and obtained an additional recognition in Clinical Pharmacology and Pharmaceutical Medicine. He has 30 years of experience in clinical pharmacology, partly in industry and mostly in academia, with a focus on early clinical development.
He is founder and President of the EUropean Federation for Exploratory Medicines Development (EUFEMED), fellow of the British Pharmacological Society, Council member for Belgium within EACPT and a former board member of the Dutch Society for Clinical Pharmacology.
Jan is appointed as Full Professor in (Clinical) Pharmacology at the Faculty of Medicine of the University of Leuven teaching (clinical) pharmacology and pharmaceutical medicine. Since 2000 he is heading the Center for Clinical Pharmacology, an Academic Research Organisation located within the University Hospitals of Leuven.
Jan is the proud father of Pieter, Fien and Emma.
Caroline Samer
SwitzerlandCaroline Samer, MD, is a Professor of Pharmacology and Clinical Toxicology at the University of Geneva, where she also heads the Clinical Pharmacology and Toxicology Division at Geneva University Hospitals. She holds several leadership roles, including Head of the Department of Anesthesiology, Pharmacology, Intensive Care and Emergency Medicine, and Delegate to the Dean’s Office of the Faculty of Medicine. Her work focuses on precision medicine, particularly pharmacogenomics, to improve therapeutic safety and efficacy through the study of gene–environment–disease interactions. With over two decades of clinical trial experience, she is recognized for her expertise in research ethics and serves as Vice-President of the Geneva Research Ethics Commission and Swissethics. She also holds prominent scientific leadership positions, including President of the Swiss societies of Pharmacology and Toxicology, Chair-elect of the Geneva Medical Society, and Chair-elect of IUPHAR.
Silje Skrede
NorwaySilje Skrede is a professor of pharmacology and vice dean at the Faculty of Medicine, University of Bergen, Norway, and a senior consultant of clinical pharmacology at Haukeland University Hospital, Bergen. Her research focuses on translational psychopharmacology, including the leadership of the Basic mechanisms of drug action group at the Mohn Research Centre for the Study of Psychosis (MRCP). She is also involved in research on biologic and targeted therapies, focusing on pharmacokinetics, therapeutic monitoring, and the clinical optimization of these drugs in different patient populations.
Cornelis Kramers
The NetherlandsCornelis Kramers is internist-clinical pharmacology and professor of medication safety in the Radboud University Center in Nijmegen. He also works in the CWZ hospital in Nijmegen, the Netherlands. He is mainly a teacher, but also performed research on medication safety and toxicology. In addition he works on the therapeutic application of psychedelics. He is past president of the Dutch Society of Clinical Pharmacology.